Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07318207 · ClinicalTrials.gov registry record · NA
Time-restricted Eating for Patients With Type 2 Diabetes
A NA study of Type 2 Diabetes, sponsored by Justin (Matt) Thomas.
- Recruiting
- Registry status
- NA
- Development phase
- 102
- Enrollment target
- 1
- Study location
NCT07318207: Recruiting NA study of Type 2 Diabetes, sponsored by Justin (Matt) Thomas.
NCT07318207 is a NA study of Type 2 Diabetes that is actively recruiting participants, run by Justin (Matt) Thomas. The registered enrollment target is 102 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07318207, a NA study of Type 2 Diabetes, is actively recruiting participants, sponsored by Justin (Matt) Thomas.
- RECRUITING
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-arm pragmatic clinical trial of time-restricted eating in patients with type 2 diabetes. Patients will be recruited from the University of Kentucky Barnstable Brown Diabetes Center. Subjects will participate in a 10-hour time-restricted eating intervention for 1-year.
Primary Outcome
HbA1c data will be gathered from patient charts from routine labs collected during clinic visits.
Conditions Studied
Interventions
- BEHAVIORAL Time-restricted eating
Study Locations (1)
Kentucky
- University of Kentucky Barnstable Brown Diabetes Center - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2026-04 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT07318207 shows while recruiting
NCT07318207 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Time-restricted eating is the first listed.
NCT07318207 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT07318207 about?
NCT07318207 is a clinical study titled "Time-restricted Eating for Patients With Type 2 Diabetes". This is a single-arm pragmatic clinical trial of time-restricted eating in patients with type 2 diabetes. Patients will be recruited from the University of Kentucky Barnstable Brown Diabetes Center. Subjects will participate in a 10-hour time-restricted eating intervention for 1-year.
What is the current status of trial NCT07318207?
This trial is currently recruiting. It is a NA study. The enrollment target is 102 participants. The study started on 2026-04. Estimated completion is 2027-06.
What conditions does trial NCT07318207 study?
This clinical trial studies the following conditions: Type 2 Diabetes.
What interventions are being tested in trial NCT07318207?
The interventions under investigation include: Time-restricted eating (BEHAVIORAL).
Who is sponsoring clinical trial NCT07318207?
This trial is sponsored by Justin (Matt) Thomas, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07318207 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07318207's enrollment target sits among peer trials
102 150th of 327 higher than 178 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia